ENDRA Life Sciences
Open
$4.78
Prev. Close
$4.70
High
$4.78
Low
$4.59
Market Snapshot
$5.82M
-0.8
-434.00
21
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company is headquartered in Ann Arbor, Michigan and currently employs 11 full-time employees. The company went IPO on 2017-06-28. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. TAEUS technology uses a pulsed energy source, specifically, radio frequency (RF), to transmit energy deep into tissue and generate ultrasonic waves based on the tissue composition (or tissue chemistry), differentiating lean and fatty tissues. These waves are then detected with ultrasound sensors at the skin surface and used to create high-contrast images using its proprietary algorithms.
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company is headquartered in Ann Arbor, Michigan and currently employs 11 full-time employees. The company went IPO on 2017-06-28. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. TAEUS technology uses a pulsed energy source, specifically, radio frequency (RF), to transmit energy deep into tissue and generate ultrasonic waves based on the tissue composition (or tissue chemistry), differentiating lean and fatty tissues. These waves are then detected with ultrasound sensors at the skin surface and used to create high-contrast images using its proprietary algorithms.
Recently from Cashu
ENDRA Life Sciences Innovates Ultrasound Imaging for Improved Liver Disease Diagnosis
ENDRA Life Sciences Advances Medical Imaging Technology for Enhanced Diagnosis ENDRA Life Sciences, a company specializing in medical imaging technology, is making significant strides in the field of…
ENDRA Life Sciences Advances Non-Invasive Imaging Technology for Liver Disease Diagnosis
ENDRA Life Sciences Enhances Medical Imaging with Innovative Technology ENDRA Life Sciences, a pioneering company in the field of medical imaging, continues to make significant strides with its develo…
ENDRA Life Sciences Enhances Non-Invasive Liver Health Imaging with ThermoSense Technology
ENDRA Life Sciences Advances Non-Invasive Imaging Technology for Liver Health ENDRA Life Sciences, a pioneering company in the field of medical imaging, continues to make significant strides in enhanc…
ENDRA Life Sciences Innovates Medical Imaging with ThermoScientific Ultrasound Technology
ENDRA Life Sciences Advances in Medical Imaging Technology ENDRA Life Sciences, a pioneering company in the field of medical imaging, continues to make significant strides with its innovative technolo…